Reference 28 2021
Ferrer G, et al.: Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL. Leukemia. 2021 Nov;35(11):3163-3175. doi: 10.1038/s41375-021-01249-7. Epub 2021 May 2. PMID: 33935280
Reference 29 2021
Bonotis P, et al.: Randomization of Clinical Trial Participants via an Integrated Web Service. Stud Health Technol Inform. 2021 May 27;281:1124-1125. doi: 10.3233/SHTI210375. PMID: 34042868
Reference 30 2021
Ghia P, Stamatopoulos K.: In CLL, epigenetics also points to the BCR. Blood. 2021 May 27;137(21):2863-2865. doi: 10.1182/blood.2020010036. PMID: 34042978
Reference 31 2021
Vlachonikola E, et al.: The Significance of B-cell Receptor Stereotypy in Chronic Lymphocytic Leukemia: Biological and Clinical Implications. Hematol Oncol Clin North Am. 2021 Aug;35(4):687-702. doi: 10.1016/j.hoc.2021.03.003. Epub 2021 May 26. PMID: 34174980
Reference 32 2021
Payne SA, et al.: MyPal: Designing and Evaluating Digital Patient-Reported Outcome Systems for Cancer Palliative Care in Europe. J Palliat Med. 2021 Jul;24(7):962-964. doi: 10.1089/jpm.2021.0120. PMID: 34128712
Reference 33 2021
Vlachonikola E, et al.: T Cell Defects and Immunotherapy in Chronic Lymphocytic Leukemia. Cancers (Basel). 2021 Jun 29;13(13):3255. doi: 10.3390/cancers13133255. PMID: 34209724